Leucine kinetics in surgical patients II: A study of the effect of malignant disease and tumour burden
β Scribed by Mr. R. A. Harrison; M. R. Lewin; D. Halliday; late C. G. Clark
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 314 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Isotope studies of protein turnover have given conflicting evidence about the effects of a malignant tumour on the protein metabolism of the host. Leucine kinetics have been studied, as an index of protein turnover, using a well established methodology. Twenty patients were studied, five with benign disease of the colon, ten with localized malignant tumours of the large bowel, and five in whom there was evidence of metastatic disease from a colonic primary. No effect was observed on the leucine turnover of the patients that might be attributable to the presence or size of the tumour burden. It is suggested that some of the previously conflicting results may be attributable to variability in the experimental design, the heterogeneous patient groups studied and the methods used to express the results obtained.
π SIMILAR VOLUMES
## Abstract Two prior doubleβblind, placeboβcontrolled, randomized trials demonstrated that glatiramer acetate (GA) reduces relapse rates in patients with relapsing remitting multiple sclerosis (RRMS). This study was designed to determine the effect, onset, and durability of any effect of GA on dis
## Background: Nod2/card15, the first identified susceptibility gene in crohn's disease (cd), is associated with ileal stenosis and increased frequency of surgery. anti-saccharomyces cerevisiae antibody (asca), a serological marker for cd, is associated with ileal location and a high likelihood for